Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$155.97 - $200.09 $11.7 Million - $15 Million
-74,970 Closed
0 $0
Q1 2022

May 05, 2022

SELL
$181.39 - $234.03 $12.6 Million - $16.3 Million
-69,476 Reduced 48.1%
74,970 $14.1 Million
Q4 2021

Feb 09, 2022

BUY
$193.69 - $247.03 $1.4 Million - $1.79 Million
7,238 Added 5.28%
144,446 $35.2 Million
Q3 2021

Nov 12, 2021

BUY
$189.29 - $209.69 $714,759 - $791,789
3,776 Added 2.83%
137,208 $26.6 Million
Q2 2021

Aug 06, 2021

BUY
$155.9 - $187.99 $1.26 Million - $1.52 Million
8,061 Added 6.43%
133,432 $24.9 Million
Q1 2021

May 07, 2021

BUY
$144.0 - $169.39 $1.45 Million - $1.7 Million
10,051 Added 8.72%
125,371 $19.7 Million
Q4 2020

Feb 12, 2021

BUY
$157.07 - $174.35 $1.09 Million - $1.21 Million
6,916 Added 6.38%
115,320 $19.1 Million
Q3 2020

Nov 10, 2020

BUY
$137.1 - $165.37 $14.9 Million - $17.9 Million
108,404 New
108,404 $17.9 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Main Street Research LLC Portfolio

Follow Main Street Research LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Main Street Research LLC, based on Form 13F filings with the SEC.

News

Stay updated on Main Street Research LLC with notifications on news.